Subclinical Hypothyroidism and Chronic Inflammation in PCOS
Primary Purpose
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis Dysfunction
Status
Not yet recruiting
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms
Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices
Sponsored by
About this trial
This is an interventional diagnostic trial for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Eligibility Criteria
Inclusion Criteria: age 18-45 years, cycle length <21 days or > 35 days, unsuccessful attempts to conceive for at least 12 months of regular intercourse with sonographically confirmed anovulation with excluded male, tubal and uterine infertility factors. Exclusion Criteria: absence of at least one ovary, previously diagnosed thyroid disease
Sites / Locations
- Jagiellonian University Medical College, Department of Gynecology and Obstetrics
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Polycystic ovary syndrome (PCOS)
Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD)
Arm Description
Women meeting the Rotterdam-ESHRE-ASRM criteria for a diagnosis of PCOS
Women meeting the WHO criteria for a diagnosis of HPOD
Outcomes
Primary Outcome Measures
Values of inflammation parameters - leukocytosis in peripheral blood in both study arms
Measurement and comparison of leukocyte count (n/µL) in peripheral blood in both study arms
Values of inflammation parameters - CRP in peripheral blood in both study arms
Measurement and comparison of concentrations of CRP (mg/l) in peripheral blood in both study arms
Values of inflammation parameters - procalcitonine in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin (μg/l) in peripheral blood in both study arms
Values of inflammation parameters - fibrinogen in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin fibrinogen (g/l) in peripheral blood in both study arms
Values of inflammation parameters - ferritin in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin ferritin (μg/l) in peripheral blood in both study arms
Values of inflammation parameters - IL-1 in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin IL-1 (pg/ml) in peripheral blood in both study arms
Values of inflammation parameters - IL-6 in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin IL-6 (pg/ml) in peripheral blood in both study arms
Values of inflammation parameters - IL-10 in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin IL-10 (pg/ml) in peripheral blood in both study arms
Values of inflammation parameters - TNF-alpha in peripheral blood in both study arms
Measurement and comparison of concentrations of procalcitonin TNF-alpha (pg/ml) in peripheral blood in both study arms
Secondary Outcome Measures
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - leukocytosis in both arms of the study
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: leukocyte count (n/µL)
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - CRP in both arms of the study
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: CRP (mg/l)
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - procalcitonin in both arms of the study
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: procalcitonin (μg/l)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (μg/l)
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (g/l)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l)
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-1
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-1 (pg/ml)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-6
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-6 (pg/ml)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-10
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-10 (pg/ml)
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha (pg/ml)
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: leukocyte count (n/µL)
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - CRP in both arms of the study
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: CRP (mg/l)
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: procalcitonin (μg/l)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF -alpha (pg/ml)
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - CRP in both arms of the study
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: CRP (mg/l)
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: leukocyte count (n/µL)
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: procalcitonin (μg/l)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l)
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - leukocytosis in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: leukocyte count (n/µL)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - CRP in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: CRP (mg/l)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - procalcitonin in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: procalcitonin (μg/l)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - fibrinogen in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: fibrinogen (μg/l)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - ferritin in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: ferritin (μg/l)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-1 in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-1 (pg/ml)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-6 in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-6 (pg/ml)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-10 in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-10 (pg/ml)
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - TNF-alpha in both arms of the study
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: TNF-alpha (pg/ml)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - leukocytosis in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: leukocyte count (n/µL)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - CRP in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: CRP (mg/l)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - procalcitonin in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: procalcitonin (μg/l)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - fibrinogen in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: fibrinogen (μg/l)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - ferritin in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: ferritin (μg/l)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-1 in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-1 (pg/ml)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-6 in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-6 (pg/ml)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-10 in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-10 (pg/ml)
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - TNF-alpha in both arms of the study
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters:TNF-alpha (pg/ml)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05842096
Brief Title
Subclinical Hypothyroidism and Chronic Inflammation in PCOS
Official Title
The Influence of Subclinical Hypothyroidism on Chronic Inflammation Activity in Women With Different PCOS Phenotypes
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2023 (Anticipated)
Primary Completion Date
September 30, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Jagiellonian University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation of cytokine production (due to insulin resistance, excess visceral fat and hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6) in relation to anti-inflammatory ones (IL-10). This condition may be an important link between obesity and insulin resistance, which is crucial in the etiopathogenesis of the syndrome. However, it is not known whether it results from the tendency to accumulate adipose tissue or is a feature of the syndrome itself. Concomitant endocrinopathies, i.e. obesity, dyslipidemia, insulin resistance, diabetes and thyroid diseases, may additionally influence the activity of chronic inflammation. There is no data indicating the relationship between chronic inflammation and PCOS phenotypes, the severity of metabolic disorders, ovarian reserve and the influence of thyroid function on its activity in PCOS.
Detailed Description
The aim of the study is:
i) to assess and compare serum concentrations of selected inflammatory markers (leucocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha) in women with different phenotypes PCOS and hypothalamic-pituitary-ovarian axis dysfunction (HPOD) (control), ii) to evaluate the impact of subclinical hypothyroidism (defined as TSH>2.5 uIU/ml, fT3 3,1-6,80 pmol/l, fT4 12,0-22,0 pmol/l), with the presence and absence of circulating antithyroid antibodies (a-TPO and a-TG), on the balance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes, iii) to assess the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices, expressed as FSH and AMH concentrations.
The study population will be characterized in terms of demographic (age, BMI), gynecological (age of first and last menstrual period, cycle length, history of reproductive organ surgeries, ultrasound measurements of endometrial width, ovarian volume) and obstetrics (pregnancies, childbirth, miscarriages) data. PCOS syndrome (and its phenotypes) will be recognized by the Rotterdam criteria. HPOD will be diagnosed according to WHO criteria. During hospitalization, blood samples will be collected for scheduled analyzes (30 ml of blood in total).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis Dysfunction
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
prospective tertiary single-centre cohort study
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Polycystic ovary syndrome (PCOS)
Arm Type
Active Comparator
Arm Description
Women meeting the Rotterdam-ESHRE-ASRM criteria for a diagnosis of PCOS
Arm Title
Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD)
Arm Type
Active Comparator
Arm Description
Women meeting the WHO criteria for a diagnosis of HPOD
Intervention Type
Diagnostic Test
Intervention Name(s)
Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
Intervention Description
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare the above parameters of peripheral blood in both arms of the study
Intervention Type
Diagnostic Test
Intervention Name(s)
Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms
Intervention Description
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha depending on the blood concentrations of TSH, a-TPO and a-TG in women in both study arms
Intervention Type
Diagnostic Test
Intervention Name(s)
Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices
Intervention Description
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha and AMH, FSH in women in both study arms
Primary Outcome Measure Information:
Title
Values of inflammation parameters - leukocytosis in peripheral blood in both study arms
Description
Measurement and comparison of leukocyte count (n/µL) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - CRP in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of CRP (mg/l) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - procalcitonine in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin (μg/l) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - fibrinogen in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin fibrinogen (g/l) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - ferritin in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin ferritin (μg/l) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - IL-1 in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin IL-1 (pg/ml) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - IL-6 in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin IL-6 (pg/ml) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - IL-10 in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin IL-10 (pg/ml) in peripheral blood in both study arms
Time Frame
up to 6 months
Title
Values of inflammation parameters - TNF-alpha in peripheral blood in both study arms
Description
Measurement and comparison of concentrations of procalcitonin TNF-alpha (pg/ml) in peripheral blood in both study arms
Time Frame
up to 6 months
Secondary Outcome Measure Information:
Title
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - leukocytosis in both arms of the study
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: leukocyte count (n/µL)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - CRP in both arms of the study
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: CRP (mg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - procalcitonin in both arms of the study
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: procalcitonin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (μg/l)
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (g/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l)
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-1
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-1 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-6
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-6 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-10
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-10 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha
Description
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: leukocyte count (n/µL)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - CRP in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: CRP (mg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: procalcitonin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF -alpha (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - CRP in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: CRP (mg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: leukocyte count (n/µL)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: procalcitonin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l)
Description
Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - leukocytosis in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: leukocyte count (n/µL)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - CRP in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: CRP (mg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - procalcitonin in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: procalcitonin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - fibrinogen in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: fibrinogen (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - ferritin in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: ferritin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-1 in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-1 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-6 in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-6 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-10 in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-10 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - TNF-alpha in both arms of the study
Description
Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: TNF-alpha (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - leukocytosis in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: leukocyte count (n/µL)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - CRP in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: CRP (mg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - procalcitonin in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: procalcitonin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - fibrinogen in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: fibrinogen (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - ferritin in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: ferritin (μg/l)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-1 in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-1 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-6 in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-6 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-10 in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-10 (pg/ml)
Time Frame
up to 6 months
Title
Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - TNF-alpha in both arms of the study
Description
Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters:TNF-alpha (pg/ml)
Time Frame
up to 6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age 18-45 years,
cycle length <21 days or > 35 days,
unsuccessful attempts to conceive for at least 12 months of regular intercourse with sonographically confirmed anovulation with excluded male, tubal and uterine infertility factors.
Exclusion Criteria:
absence of at least one ovary,
previously diagnosed thyroid disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Iwona M. Gawron, Ph.D.
Phone
+48 12 4248570
Email
iwona.gawron@uj.edu.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Robert Jach, Prof., Ph.D.
Phone
+48 12 4248571
Email
robert.jach@uj.edu.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Jach, Prof., Ph.D.
Organizational Affiliation
Jagiellonian University
Official's Role
Study Chair
Facility Information:
Facility Name
Jagiellonian University Medical College, Department of Gynecology and Obstetrics
City
Kraków
ZIP/Postal Code
31-501
Country
Poland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Iwona M. Gawron, Ph.D.
Phone
+48 12 4248570
Email
iwona.gawron@uj.edu.pl
First Name & Middle Initial & Last Name & Degree
Robert Jach, Prof.
Phone
+48 12 4248571
Email
robert.jach@uj.edu.pl
First Name & Middle Initial & Last Name & Degree
Iwona M. Gawron, Ph.D.
First Name & Middle Initial & Last Name & Degree
Krzysztof Skotniczny, Ph.D.
First Name & Middle Initial & Last Name & Degree
Rafał Baran, M.D.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Subclinical Hypothyroidism and Chronic Inflammation in PCOS
We'll reach out to this number within 24 hrs